Raynaud's phenomenon: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(6 intermediate revisions by 2 users not shown) | |||
Line 15: | Line 15: | ||
{{Raynaud's phenomenon}} | {{Raynaud's phenomenon}} | ||
'''Editors-In-Chief:''' Asghar Fakhri, M.D. | '''Editors-In-Chief:''' Asghar Fakhri, M.D.; Duane S. Pinto, M.D. and [[User:C Michael Gibson|C. Michael Gibson, M.S., M.D.]] | ||
{{SK}} Raynaud phenomenon; Raynaud's disease | |||
==[[Raynaud's phenomenon overview|Overview]]== | ==[[Raynaud's phenomenon overview|Overview]]== | ||
==[[Raynaud's phenomenon pathophysiology|Pathophysiology]]== | ==[[Raynaud's phenomenon pathophysiology|Pathophysiology]]== | ||
Line 30: | Line 30: | ||
==[[Raynaud's phenomenon risk factors|Risk Factors]]== | ==[[Raynaud's phenomenon risk factors|Risk Factors]]== | ||
==[[Raynaud's phenomenon natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | |||
==[[Raynaud's phenomenon natural history|Natural History, Complications and Prognosis]]== | |||
== Diagnosis == | == Diagnosis == | ||
[[Raynaud's phenomenon history and symptoms| History and Symptoms]] | [[Raynaud's phenomenon physical examination | Physical Examination]] | [[Raynaud's phenomenon laboratory findings | Laboratory Findings | [[Raynaud's phenomenon history and symptoms| History and Symptoms]] | [[Raynaud's phenomenon physical examination | Physical Examination]] | [[Raynaud's phenomenon laboratory findings | Laboratory Findings]] | [[Raynaud's phenomenon other diagnostic studies|Other diagnostic studies]] | ||
==Treatment== | ==Treatment== | ||
[[Raynaud's phenomenon medical therapy|Medical therapy]] | [[Raynaud's phenomenon primary prevention|Primary | [[Raynaud's phenomenon medical therapy|Medical therapy]] | [[Raynaud's phenomenon primary prevention|Primary prevention]] | [[Raynaud's phenomenon cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Raynaud's phenomenon future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | |||
:[[Raynaud's phenomenon case study one|Case #1]] | |||
== | == Related Chapters == | ||
* [[CREST syndrome]] | * [[CREST syndrome]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] |
Latest revision as of 19:32, 8 November 2012
For patient information click here
Raynaud's phenomenon | |
![]() | |
---|---|
Hands with Raynaud's phenomenon | |
ICD-10 | I73.0 |
ICD-9 | 443.0 |
DiseasesDB | 25933 |
MeSH | D011928 |
Raynaud's phenomenon Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Raynaud's phenomenon On the Web |
American Roentgen Ray Society Images of Raynaud's phenomenon |
Editors-In-Chief: Asghar Fakhri, M.D.; Duane S. Pinto, M.D. and C. Michael Gibson, M.S., M.D.
Synonyms and keywords: Raynaud phenomenon; Raynaud's disease
Overview
Pathophysiology
Causes
Differentiating Raynaud's phenomenon from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other diagnostic studies
Treatment
Medical therapy | Primary prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related Chapters